DK0497956T3 - Præparater med reguleret frigivelse - Google Patents

Præparater med reguleret frigivelse

Info

Publication number
DK0497956T3
DK0497956T3 DK91915434.4T DK91915434T DK0497956T3 DK 0497956 T3 DK0497956 T3 DK 0497956T3 DK 91915434 T DK91915434 T DK 91915434T DK 0497956 T3 DK0497956 T3 DK 0497956T3
Authority
DK
Denmark
Prior art keywords
complex
active agent
composition
polycarbophil
polymeric
Prior art date
Application number
DK91915434.4T
Other languages
English (en)
Inventor
Ramesh N Acharya
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/570,340 external-priority patent/US5110605A/en
Priority claimed from US07/580,854 external-priority patent/US5102666A/en
Priority claimed from US07/678,814 external-priority patent/US5686094A/en
Application filed by Theratech Inc filed Critical Theratech Inc
Application granted granted Critical
Publication of DK0497956T3 publication Critical patent/DK0497956T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8194—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
DK91915434.4T 1990-08-21 1991-08-20 Præparater med reguleret frigivelse DK0497956T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/570,340 US5110605A (en) 1990-08-21 1990-08-21 Calcium polycarbophil-alginate controlled release composition and method
US07/580,854 US5102666A (en) 1990-09-11 1990-09-11 Calcium polycarbophil controlled release composition and method
US07/678,814 US5686094A (en) 1991-04-01 1991-04-01 Controlled release formulations for the treatment of xerostomia

Publications (1)

Publication Number Publication Date
DK0497956T3 true DK0497956T3 (da) 1996-08-12

Family

ID=27416097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915434.4T DK0497956T3 (da) 1990-08-21 1991-08-20 Præparater med reguleret frigivelse

Country Status (9)

Country Link
EP (1) EP0497956B1 (da)
JP (1) JP3064417B2 (da)
AT (1) ATE137404T1 (da)
AU (1) AU8444291A (da)
DE (1) DE69119217T2 (da)
DK (1) DK0497956T3 (da)
ES (1) ES2088500T3 (da)
GR (1) GR3020502T3 (da)
WO (1) WO1992003124A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661171A (en) * 1992-07-02 1997-08-26 Oramed, Inc. Controlled release pilocarpine delivery system
EP0659077A1 (en) * 1992-07-02 1995-06-28 TheraTech, Inc. Controlled release pilocarpine delivery system
US5885552A (en) * 1993-01-19 1999-03-23 Gillette Canada Inc. Mouthrinse
EP0681466B1 (en) * 1993-01-19 2001-09-19 The Gillette Company Mouthrinse
GB2279871B (en) * 1993-06-23 1997-05-07 Jevco Ltd Drug retention systems for use in aquaculture
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU748804B2 (en) * 1995-07-20 2002-06-13 Smithkline Beecham Plc Paroxetine controlled release compositions
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
US5912007A (en) * 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
IT1284874B1 (it) 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
DE19637792A1 (de) * 1996-09-17 1998-03-19 Huels Chemische Werke Ag Katalysator und Verfahren zur katalytischen Abgasreinigung im DMT-Prozeß
EP1624864B1 (en) * 2003-05-14 2014-11-26 Danisco US Inc. Controlled release of active agents utilizing repeat sequence protein polymers
EP1793799B1 (en) * 2004-08-02 2010-05-05 Glaxo Group Limited Novel composition for treating xerostomia
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
WO2007017712A1 (en) * 2005-08-11 2007-02-15 Promedon Do Brasil Produtos Medico-Hospitalares Ltda. Composition comprising polymeric, water-insoluble, anionic particles, processes and uses
TW201010743A (en) * 2008-09-05 2010-03-16 Otsuka Pharma Co Ltd Pharmaceutical solid preparation
EP3145548B1 (en) 2014-05-22 2022-04-13 University of Copenhagen Aqueous gel composition and its use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
IE63392B1 (en) * 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions
CA2003808C (en) * 1988-11-28 1999-11-09 Eugene Joseph Sehm Crosslinked polyacrylic acid
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
ATE181824T1 (de) * 1989-10-31 1999-07-15 Columbia Lab Inc Mittel zur feuchthaltung von gewebe und verfahren

Also Published As

Publication number Publication date
JPH05502894A (ja) 1993-05-20
EP0497956B1 (en) 1996-05-01
WO1992003124A1 (en) 1992-03-05
JP3064417B2 (ja) 2000-07-12
ES2088500T3 (es) 1996-08-16
EP0497956A4 (en) 1993-03-31
DE69119217T2 (de) 1996-10-31
DE69119217D1 (de) 1996-06-05
EP0497956A1 (en) 1992-08-12
ATE137404T1 (de) 1996-05-15
GR3020502T3 (en) 1996-10-31
AU8444291A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
DK0497956T3 (da) Præparater med reguleret frigivelse
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
IT1255390B (it) Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione
HUP9800794A2 (hu) (S)-oxi-butinin és (S)-dezetil-oxi-butinin alkalmazása vizelet inkontinencia kezelésére alkalmazható gyógyszerkészítmények előállítására és a vegyületek előállítása
DE69020422D1 (de) Zusammensetzung in Form eines Schaumes enthaltend 5-Aminosalicylic Säure zur intra-rektal Verabreichung.
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
GB9220667D0 (en) Improvements in or relating to dioic acids
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE69025271D1 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
DK586387D0 (da) Piperidinderivater til behandling af smertetilstande
DE69615400D1 (de) 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen
DE59002748D1 (de) Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
ATE7107T1 (de) Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln.
DE69633393D1 (de) Mitteln zur behandlung von auto-immun krankheiten
MY104521A (en) Treatment of depression.
DE3276786D1 (en) Medical process and preparation
US4250167A (en) Methods for reducing calcium deposits
DE69430807D1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
ATE164766T1 (de) Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen
ATE345138T1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози
HUT49809A (en) Process for producing pharmaceutical composition for treating miohypoplasia of young pigs
ATE81586T1 (de) Arzneiformulierung zur transdermalen absorption des wirkstoffs sowie verfahren zu deren herstellung.